{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:45:53Z","timestamp":1791222353169,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"2","funder":[{"name":"Association d'aide \u00e0 la recherche m\u00e9dicale Andr\u00e9 V\u00e9sale","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2023,9,12]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Intranasal sufentanil is a potent opioid which can be used in patients with traumatic injuries presenting to the ED. Although previous studies have demonstrated the superiority of intranasal sufentanil over intravenous morphine in terms of pain relief, its clinical superiority in patients with traumatic injuries receiving adequate multimodal analgesia with acetaminophen and non-steroidal anti-inflammatory drugs is uncertain. We compared pain relief offered by intranasal sufentanil with that offered by oral and intravenous opioids in patients with acute traumatic injuries also receiving a specified regimen of non-opioid treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this single-centre, open-label, parallel-group, randomised controlled superiority trial conducted between January 2020 and February 2022, trauma patients presenting to the ED with a pain score of \u22657 on a visual analogue scale (VAS) were randomised to receive either intranasal sufentanil or other oral\/intravenous opioids alongside oral\/intravenous acetaminophen and non-steroidal anti-inflammatory drugs. The primary outcome was reduction in VAS score 15\u201320\u2009min after randomisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>An intention-to-treat analysis included 170 out of 205 patients screened for inclusion. The intranasal sufentanil group (83 patients) showed a significantly greater reduction in pain when compared with the oral\/intravenous opioid group (87 patients) 15\u201320\u2009min after randomisation (reduction in VAS score 3.0 (IQR 1.7\u20135.0) vs 1.5 (IQR 0.9\u20133.0); p&lt;0.001). Similarly, a greater reduction in pain was observed in the intranasal sufentanil group 60 min after randomisation (5.0 (IQR 3.0\u20137.0) vs 3.0 (IQR 2.0\u20135.3); p&lt;0.001). However, side effects were more frequent in the intervention group (71.1% vs 23%; p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Intranasal sufentanil was associated with more effective pain relief than oral\/intravenous opioids in patients with traumatic injuries treated with coanalgesia. Intranasal sufentanil could be considered for the management of pain in patients with traumatic injuries associated with severe pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04137198\">NCT04137198<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2023-213353","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:20:18Z","timestamp":1695921618000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of intranasal sufentanil on acute post-traumatic pain in the emergency department: a randomised controlled trial"],"prefix":"10.1136","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct04137198","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04137198","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-0491","authenticated-orcid":false,"given":"Stefano","family":"Malinverni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9958-8091","authenticated-orcid":false,"given":"Bernard","family":"Kreps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7895-3550","authenticated-orcid":false,"given":"Thibault","family":"Lucaccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9799-3173","authenticated-orcid":false,"given":"Fatima-Zohra","family":"Bouazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-9240","authenticated-orcid":false,"given":"Magali","family":"Bartiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6536-4548","authenticated-orcid":false,"given":"Alain","family":"Plumacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Pascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-8071","authenticated-orcid":false,"given":"Pierre","family":"Youatou Towo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2025062323250788000_41.2.83.1","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2002.32643"},{"key":"2025062323250788000_41.2.83.2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzi022"},{"key":"2025062323250788000_41.2.83.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000797","article-title":"Improving timely analgesia administration for musculoskeletal pain in the emergency Department","volume":"9","author":"Woolner","year":"2020","journal-title":"BMJ Open Qual"},{"key":"2025062323250788000_41.2.83.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13049-015-0166-3","article-title":"Assessment of pain in a Norwegian emergency Department","volume":"23","author":"Dale","year":"2015","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2025062323250788000_41.2.83.5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jemermed.2018.01.020","article-title":"The treatment of acute pain in the emergency Department: A white paper position statement prepared for the American Academy of emergency medicine","volume":"54","author":"Motov","year":"2018","journal-title":"J Emerg Med"},{"key":"2025062323250788000_41.2.83.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12245-016-0102-y","article-title":"Increased analgesia administration in emergency medicine after implementation of revised guidelines","volume":"9","author":"Van Woerden","year":"2016","journal-title":"Int J Emerg Med"},{"key":"2025062323250788000_41.2.83.7","doi-asserted-by":"crossref","DOI":"10.1097\/PR9.0000000000001048","article-title":"Pain severity at emergency Department discharge as a Predictor for Chronification of pain","volume":"7","author":"Ten Doesschate","year":"2022","journal-title":"Pain Rep"},{"key":"2025062323250788000_41.2.83.8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.aenj.2015.11.001","article-title":"Time to analgesia and pain score documentation best practice standards for the emergency Department \u2013 A literature review","volume":"19","author":"Hatherley","year":"2016","journal-title":"Australas Emerg Nurs J"},{"key":"2025062323250788000_41.2.83.9","doi-asserted-by":"crossref","first-page":"120994","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int J Pharm"},{"key":"2025062323250788000_41.2.83.10","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5177","article-title":"Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency Department: a narrative review","volume":"9","author":"Pansini","year":"2021","journal-title":"Ann Transl Med"},{"key":"2025062323250788000_41.2.83.11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jemermed.2017.01.020","article-title":"Review of Intranasally administered medications for use in the emergency Department","volume":"53","author":"Bailey","year":"2017","journal-title":"J Emerg Med"},{"key":"2025062323250788000_41.2.83.12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.annemergmed.2017.02.015","article-title":"When to pick the nose: out-of-hospital and emergency Department intranasal administration of medications","volume":"70","author":"Rech","year":"2017","journal-title":"Ann Emerg Med"},{"key":"2025062323250788000_41.2.83.13","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/476161","article-title":"Prehospital medication administration: A randomised study comparing intranasal and intravenous routes","volume":"2012","author":"McDermott","year":"2012","journal-title":"Emerg Med Int"},{"key":"2025062323250788000_41.2.83.14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1460-9592.2010.03411.x","article-title":"Aspects of pharmacokinetics and pharmacodynamics of Sufentanil in pediatric practice","volume":"21","author":"Lundeberg","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"2025062323250788000_41.2.83.15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1213\/00000539-199001000-00003","article-title":"Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and Sufentanil","volume":"70","author":"Bailey","year":"1990","journal-title":"Anesth Analg"},{"key":"2025062323250788000_41.2.83.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002849","article-title":"Intranasal Sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study","volume":"16","author":"Blancher","year":"2019","journal-title":"PLOS Med"},{"key":"2025062323250788000_41.2.83.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2012.02.019"},{"key":"2025062323250788000_41.2.83.18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jemermed.2018.12.002","article-title":"Intranasal Sufentanil versus intravenous morphine for acute pain in the emergency Department: A randomized pilot trial","volume":"56","author":"Sin","year":"2019","journal-title":"J Emerg Med"},{"key":"2025062323250788000_41.2.83.19","first-page":"116","article-title":"Intranasal Sufentanil versus intravenous morphine sulfate in pain management of patients with extremity trauma","volume":"2","author":"Arhami Dolatabadi","year":"1970","journal-title":"Iran J Emerg Med"},{"key":"2025062323250788000_41.2.83.20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11739-019-02088-2","article-title":"Intranasal Sufentanil given in the emergency Department triage zone for severe acute traumatic pain: a randomized double-blind controlled trial","volume":"14","author":"Lemoel","year":"2019","journal-title":"Intern Emerg Med"},{"key":"2025062323250788000_41.2.83.21","unstructured":"Malinverni S Kreps B , Lucaccioni T , et al . Intranasal Sufentanil vs oral\/IV opioid for severe traumatic pain Dataset. 2023. doi:10.6084\/m9.figshare.22348558.v2"},{"key":"2025062323250788000_41.2.83.22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajem.2018.01.008","article-title":"A systematic review of the pain scales in adults: which to use?","volume":"36","author":"Karcioglu","year":"2018","journal-title":"Am J Emerg Med"},{"key":"2025062323250788000_41.2.83.23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/14604086211032459","article-title":"Intranasal Sufentanil compared with a classic protocol for acute pain management in an emergency Department: A prospective sequential study","volume":"25","author":"Kreps","year":"2023","journal-title":"Trauma"},{"key":"2025062323250788000_41.2.83.24","doi-asserted-by":"publisher","DOI":"10.1136\/emj.18.3.205"},{"key":"2025062323250788000_41.2.83.25","doi-asserted-by":"publisher","DOI":"10.1111\/jan.14565"},{"key":"2025062323250788000_41.2.83.26","unstructured":"Hachimi-Idrissi S , Coffey F , Dobias V , et al . Guidelines for the management of acute pain in emergency situations 2020, Available: https:\/\/eusem.org\/images\/EUSEM_EPI_GUIDELINES_MARCH_2020.pdf [Accessed 14 Mar 2023]."},{"key":"2025062323250788000_41.2.83.27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2167-0846.1000153","article-title":"The decrease of pain severity among patients with isolated closed fractures of extremity and Clavicle in emergency Department","volume":"03","author":"Hidayat L","year":"2014","journal-title":"J Pain Relief"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2023-213353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T06:25:26Z","timestamp":1750746326000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2023-213353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/emermed-2023-213353"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2023-213353","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}